FDA Will Narrow Topics For Advisory Committees In Response To HRG Suit
Executive Summary
FDA will ask more directed questions of its advisory committees as a way to narrow the amount of information from NDAs that will be provided to the committees, FDA's Office of Training and Communications Director Nancy Smith, PhD, told the Regulatory Affairs Professionals Society Oct. 5.